As individuals with Alzheimer's disease (AD) move from the mild cognitive impairment stage to moderate and severe dementia, ...

A molecule produced by cancer cells can shield the brain from Alzheimer’s disease in mice. For decades, researchers have ...

Cleveland researchers achieve full cognitive recovery in mice, offering new hope for dementia patients.

The pursuit of a cure for Alzheimer's disease is becoming an increasingly competitive and contentious quest, with recent ...

A blood test, combined with an ultrathin material derived from graphite, could significantly advance efforts to detect ...

The drug will advance to a multiple ascending dose study, with later plans to initiate a Phase II/III trial.

Alzheimer’s affects over two million Americans and is the leading cause of dementia. It is progressive, incurable, and driven ...

Researchers in Toronto are proposing a new theory about Alzheimer’s disease, suggesting it might not actually be a brain disease.

The finger-prick blood test employs a plasma separation card, designed to cut costs and simplify testing procedures.

David Diebold took on the HURT100 race three years after his father was diagnosed with a form of Alzheimer’s disease.

NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel ...

Researchers found that blood samples collected at home and mailed in can reliably track early Alzheimer’s-related brain ...